Caveolin 2 抗体
Quick Overview for Caveolin 2 抗体 (ABIN872473)
抗原
See all Caveolin 2 (CAV2) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Caveolin-2
-
亚型
- IgG
-
-
anti-Caveolin 2 (CAV2) (N-Term) antibody
CAV2 适用: 人 WB, IHC (p), IF, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 1-86) antibodyCAV2 适用: 人 WB, ELISA, IHC, FACS 宿主: 小鼠 Monoclonal 5E9E2 unconjugated
anti-Caveolin 2 (CAV2) (N-Term) antibodyCAV2 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 兔, 绵羊, 猴, 马, Pig, Hamster, 山羊, 驴, 小鸡, Cat, Avian WB, IHC (p), IF, IHC (fro) 宿主: 山羊 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 1-17) antibodyCAV2 适用: 人, 小鼠, 大鼠 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 3-64) antibodyCAV2 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) antibodyCAV2 适用: 人 WB, IHC, IP 宿主: 兔 Monoclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 1-17), (N-Term) antibodyCAV2 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 1-162) antibodyCAV2 适用: 人, 小鼠, 大鼠 WB, IHC, IF, FACS, ICC 宿主: 兔 Polyclonal unconjugated
anti-Caveolin 2 (CAV2) (AA 11-44), (N-Term) antibodyCAV2 适用: 人 WB, IHC (p), IF, FACS 宿主: 兔 Polyclonal RB16483 unconjugated
anti-Caveolin 2 (CAV2) (N-Term) antibodyCAV2 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 兔, 绵羊, 马 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
WB 1:100-1000
IHC-P 1:100-500
IF(IHC-P) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C
-
有效期
- 12 months
-
-
- Caveolin 2 (CAV2)
-
别名
- Caveolin-2
-
背景
-
May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. The Ser-36 phosphorylated form has a role in modulating mitosis in endothelial cells. Positive regulator of cellular mitogenesis of the MAPK signaling pathway. Required for the insulin-stimulated nuclear translocation and activation of MAPK1 and STAT3, and the subsequent regulation of cell cycle progression.Tissue specificity: Expressed in endothelial cells, smooth muscle cells, skeletal myoblasts and fibroblasts.Cellular localization: Nucleus. Cytoplasm. Golgi apparatus membrane. Cell membrane. Membrane > caveola. Potential hairpin-like structure in the membrane. Membrane protein of caveolae. Tyr-19-phosphorylated form is enriched at sites of cell-cell contact and is translocated to the nucleus in complex with MAPK1 in response to insulin (By similarity). Tyr-27-phosphorylated form is located both in the cytoplasm and plasma membrane. CAV1-mediated Ser-23-phosphorylated form locates to the plasma membrane. Ser-36-phosphorylated form resides in intracellular compartments.
Synonyms: CAV, CAV2, CAV2_HUMAN, Caveolae protein 20 kD, Caveolin 2, Caveolin2, Caveolin 2 isoform a and b, Caveolin 2 isoform c, Caveolin-2, MGC12294.
-
基因ID
- 858
-
途径
- Regulation of G-Protein Coupled Receptor Protein Signaling, Skeletal Muscle Fiber Development
抗原
-
